Kadimastem

Stem Cell for the treatment of diabetes mellitus and amyotrophic lateral sclerosis (ALS)

placeNess Ziona, Center District, Israel calendar_todayFounded 2009 groups31 employees language kadimastem.com

Social engagement

Social engagement: 2.5K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record.

Investor typeCountShare
Venture capital111%
Bank & private debt111%
Other / undisclosed778%

Recent activity

1 Jul 2026
Milestone
regulatory
27 May 2026
Partnership
Eledon Pharmaceuticals, Inc.
6 May 2026
Event
Swiss Biotech Day
Coming soon